1st Quarter - Report

FAEGRE DRINKER BIDDLE & REATH LLP for INTERNATIONAL MYELOMA FOUNDATION

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 1730/ S. 741 The Cancer Drug Parity Act.

LobbyistCovered position, as disclosed
PHIL GINGREY —
JONATHAN M. HEPPEN —
JEREMY SCOTT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 741 (116th), H.R. 1730 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.